MATINAS BIOPHARMA HOLDINGS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $3.8M | $19.9M | $12.4M |
| FY2019 | $7.2M | $40.2M | $22.2M |
| FY2020 | $7.2M | $71.0M | $12.4M |
| FY2021 | $8.8M | $61.3M | $21.0M |
| FY2022 | $8.2M | $44.8M | $6.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | $3.8M | $19.9M | $12.4M |
| FY2019 | $7.2M | $40.2M | $22.2M |
| FY2020 | $7.2M | $71.0M | $12.4M |
| FY2021 | $8.8M | $61.3M | $21.0M |
| FY2022 | $8.2M | $44.8M | $6.8M |